Scientific

MK5 Microarray Data


Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

Proteome Analysis

Below the proteome analysis is presented. The analysis methods are presented in the paper Propagating Differential Gene Expression in Protein Interaction Networks. If you are interested in the most reliable results choose the

  • value_type as 'ranked' since this provides a very robust analysis method.
  • intercation map as 'high confidence'
  • network_comparison type as 'Divided' since this leads to a natural grouping of similar proteins
  • filtered as 'true' since this will only use the microarray measurements that have a sufficiently large confidence level.

  • Navigation/Query Panel:
    Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
    Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
    Results: HTML CSV LaTeX Showing element 2013 to 2062 of 8289 in total
    Value Type: Measured
    Network Comparison Type: Divided
    Filtered: 1
    \def\wcA{0.14285714285714\textwidth} \def\wcB{0.14285714285714\textwidth} \def\wcC{0.14285714285714\textwidth} \def\wcD{0.14285714285714\textwidth} \def\wcE{0.14285714285714\textwidth} \def\wcF{0.14285714285714\textwidth} \begin{longtable}{|c|c|c|c|c|c|} \hline \parbox{\wcA}{\vspace{3pt}\noindent Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Interaction Map\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent network\_comparison\vspace{3pt}}\\ \hline \hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1007\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial precursor (ec 1.5.5.1) (etf-qo) (etf-ubiquinone oxidoreductase) (etf dehydrogenase) (electron-transferring- flavoprotein dehydrogenase). [source:swissprot;acc:q16134]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 8161.56\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 8472.15\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.03806\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent hypoxia-inducible factor-3 alpha isoform a; inhibitory pas domain protein. [source:refseq;acc:nm\_152794]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5707.73\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 6249.1\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.09485\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1008\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent senescence marker protein-30 (smp-30) (regucalcin) (rc). [source:swissprot;acc:q15493]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6913.4\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 7176.31\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.03803\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent single-minded homolog 1. [source:swissprot;acc:p81133]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5707.73\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 6249.1\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.09485\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1009\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent calponin h2, smooth muscle (neutral calponin). [source:swissprot;acc:q99439]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 8086.9\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 8394.45\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.03803\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent synapsin iii. [source:swissprot;acc:o14994]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent High confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 5791.82\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 6340.86\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent 1.0948\vspace{3pt}}}\\\cline{1-2} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1010\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent aspartate beta-hydroxylase isoform b; junctin isoform 1; junctate; aspartyl/asparaginyl-beta-hydroxylase; peptide-aspartate beta-dioxygenase; humbug. [source:refseq;acc:nm\_032468]\vspace{3pt}}&&&&\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent guanine nucleotide-binding protein g(q), alpha subunit. [source:swissprot;acc:p50148]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent 7733.46\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 8027.45\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent 1.03802\vspace{3pt}}}\\\cline{1-2}\cline{4-5} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1011\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent calponin h1, smooth muscle (basic calponin) (calponin 1). [source:swissprot;acc:p51911]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent 8087.01\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 8394.5\vspace{3pt}}&\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent hairy/enhancer-of-split related with yrpw motif 1 (hairy and enhancer of split related-1) (hesr-1) (cardiovascular helix-loop-helix factor 2) (hes-related repressor protein 2 herp2). [source:swissprot;acc:q9y5j3]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent High confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 5791.82\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 6340.86\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent 1.0948\vspace{3pt}}}\\\cline{1-2} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1012\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent actin binding lim protein 2. [source:refseq;acc:nm\_032432]\vspace{3pt}}&&&&\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent calponin, acidic isoform (calponin 3). [source:swissprot;acc:q15417]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent 8087\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 8394.49\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent 1.03802\vspace{3pt}}}\\\cline{1-2}\cline{4-5} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1013\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent guanine nucleotide-binding protein g(y), alpha subunit (alpha-11). [source:swissprot;acc:p29992]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent 7733.95\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 8028.03\vspace{3pt}}&\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent hairy/enhancer-of-split related with yrpw motif-like. [source:refseq;acc:nm\_014571]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5791.82\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 6340.86\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.0948\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1014\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent dihydroorotate dehydrogenase, mitochondrial precursor (ec 1.3.3.1) (dihydroorotate oxidase) (dhodehase) (fragment). [source:swissprot;acc:q02127]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 7878.21\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 8177.69\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.03801\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent synapsin ii. [source:swissprot;acc:q92777]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent High confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 5791.82\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 6340.86\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent 1.0948\vspace{3pt}}}\\\cline{1-2} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1015\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent mitochondrial ribosome recycling factor. [source:refseq;acc:nm\_138777]\vspace{3pt}}&&&&\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent protein arginine n-methyltransferase 4 (ec 2.1.1.-). [source:swissprot;acc:q9nr22]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent 7877.17\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 8176.48\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent 1.038\vspace{3pt}}}\\\cline{1-2}\cline{4-5} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1016\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent alpha glucosidase ii alpha subunit; likely ortholog of mouse g2an alpha glucosidase 2, alpha neutral subunit. [source:refseq;acc:nm\_014610]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent 8456.9\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 8778.27\vspace{3pt}}&\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent peroxisomal targeting signal 1 receptor (peroxismore receptor 1) (peroxisomal c-terminal targeting signal import receptor) (pts1-bp) (peroxin-5) (pts1 receptor). [source:swissprot;acc:p50542]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent High confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 5791.82\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 6340.86\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent 1.0948\vspace{3pt}}}\\\cline{1-2} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1017\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent hairy/enhancer-of-split related with yrpw motif 2; gridlock; hes-related repressor protein 1. [source:refseq;acc:nm\_012259]\vspace{3pt}}&&&&\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent lysine-deficient protein kinase 2; mitogen-activated protein kinase kinase kinase; serologically defined colon cancer antigen 43. [source:refseq;acc:nm\_006648]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Low confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 7769.69\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 8064.74\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent 1.03797\vspace{3pt}}}\\\cline{1-2} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1018\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent protein kinase, lysine deficient 4; putative protein kinase wnk4. [source:refseq;acc:nm\_032387]\vspace{3pt}}&&&&\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent transcription factor hes-1 (hairy and enhancer of split 1) (hairy- like) (hhl) (hairy homolog). [source:swissprot;acc:q14469]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent High confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 5791.82\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 6340.86\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent 1.0948\vspace{3pt}}}\\\cline{1-2} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1019\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent delta3,5-delta2,4-dienoyl-coa isomerase, mitochondrial precursor (ec 5.3.3.-). [source:swissprot;acc:q13011]\vspace{3pt}}&&&&\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent protein kinase, lysine deficient 3. [source:refseq;acc:nm\_020922]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 7769.69\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 8064.74\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.03797\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1020\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent actin-binding lim protein 1 isoform a; lim actin-binding protein 1; limatin; actin-binding lim protein. [source:refseq;acc:nm\_002313]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5791.82\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 6340.86\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.0948\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent protein kinase, lysine deficient 1; kinase deficient protein. [source:refseq;acc:nm\_018979]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Low confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 7769.69\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 8064.74\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent 1.03797\vspace{3pt}}}\\\cline{1-2} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1021\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent exonuclease nef-sp. [source:refseq;acc:nm\_030941]\vspace{3pt}}&&&&\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent synapsin i (brain protein 4.1). [source:swissprot;acc:p17600]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5791.82\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 6340.86\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.0948\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1022\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent mitochondrial import inner membrane translocase subunit tim13 b. [source:swissprot;acc:q9y5l4]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 7877.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 8176.51\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.03796\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent protein kinase clk2 (ec 2.7.1.-) (cdc-like kinase 2). [source:swissprot;acc:p49760]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6435.94\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 7045.75\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.09475\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1023\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent adapter-related protein complex 2 beta 1 subunit (beta-adaptin) (plasma membrane adaptor ha2/ap2 adaptin beta subunit) (clathrin assembly protein complex 2 beta large chain) (ap105b). [source:swissprot;acc:p21851]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 7716.88\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 8009.78\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.03796\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent protein kinase clk3 (ec 2.7.1.-) (cdc-like kinase 3). [source:swissprot;acc:p49761]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6435.02\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 7044.65\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.09474\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1024\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent 26s protease regulatory subunit 7 (mss1 protein). [source:swissprot;acc:p35998]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 8385.76\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 8703.92\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.03794\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent cysteine-rich protein 1 (cysteine-rich intestinal protein) (crip) (cysteine-rich heart protein) (hcrhp). [source:swissprot;acc:p50238]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent 5706.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 6245.55\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.09446\vspace{3pt}}\\\cline{1-2}\cline{4-6} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1025\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent phosphomannomutase 2 (ec 5.4.2.8) (pmm 2). [source:swissprot;acc:o15305]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent 5511.96\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 6031.95\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.09434\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent striated muscle activator of rho-dependent signaling. [source:refseq;acc:nm\_139166]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent 7445.04\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 7727.46\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent 1.03793\vspace{3pt}}}\\\cline{1-2}\cline{4-5} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1026\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent guanine nucleotide-binding protein g(z), alpha subunit (g(x) alpha chain) (gz-alpha). [source:swissprot;acc:p19086]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent 7728.58\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 8021.71\vspace{3pt}}&\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent phosphomannomutase 1 (ec 5.4.2.8) (pmm 1) (pmmh-22). [source:swissprot;acc:q92871]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5509.89\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 6029.29\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.09427\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1027\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent protein arginine n-methyltransferase 1 (ec 2.1.1.-) (interferon receptor 1-bound protein 4). [source:swissprot;acc:q99873]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 7877.81\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 8176.55\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.03792\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent s-adenosylmethionine synthetase gamma form (ec 2.5.1.6) (methionine adenosyltransferase) (adomet synthetase) (mat-ii). [source:swissprot;acc:p31153]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6123.15\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 6700.05\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.09422\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1028\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent guanine nucleotide-binding protein g(t), alpha-1 subunit (transducin alpha-1 chain). [source:swissprot;acc:p11488]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 7727.97\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 8020.98\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.03792\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent nicotinate-nucleotide pyrophosphorylase [carboxylating] (ec 2.4.2.19) (quinolinate phosphoribosyltransferase [decarboxylating]) (qaprtase) (qprtase). [source:swissprot;acc:q15274]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent 5704\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 6241.36\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.09421\vspace{3pt}}\\\cline{1-2}\cline{4-6} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1029\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent beta-catenin (pro2286). [source:swissprot;acc:p35222]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent 5635.26\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 6166.09\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.0942\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent inositol-1(or 4)-monophosphatase 2 (ec 3.1.3.25) (impase 2) (imp 2) (inositol monophosphatase 2) (myo-inositol monophosphatase a2). [source:swissprot;acc:o14732]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 7809.04\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 8105.05\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.03791\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1030\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent casein kinase i, epsilon isoform (ec 2.7.1.-) (cki-epsilon) (ckie). [source:swissprot;acc:p49674]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5048.33\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 5523.85\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.09419\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent guanine nucleotide-binding protein g(t), alpha-2 subunit (transducin alpha-2 chain). [source:swissprot;acc:p19087]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent 7727.68\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 8020.64\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.03791\vspace{3pt}}\\\cline{1-2}\cline{4-6} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1031\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent guanine nucleotide-binding protein g(i), alpha-2 subunit (adenylate cyclase-inhibiting g alpha protein). [source:swissprot;acc:p04899]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent 7724.11\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 8016.44\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.03785\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent membrane protein expressed in epithelial-like lung adenocarcinoma. [source:refseq;acc:nm\_024792]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6136.99\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 6714.98\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.09418\vspace{3pt}}\\\hline nd{longtable}
    Legend:
    - Rank is the rank after comparing the two networks
    - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray
    - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.
    - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them
    - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.
    - Filtered specifies whether we only included the high confidence microarry measurements or not.

    - http://analysis.yellowcouch.org/